109 related articles for article (PubMed ID: 10360732)
21. ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.
Shiosaki K; Jenner P; Asin KE; Britton DR; Lin CW; Michaelides M; Smith L; Bianchi B; Didomenico S; Hodges L; Hong Y; Mahan L; Mikusa J; Miller T; Nikkel A; Stashko M; Witte D; Williams M
J Pharmacol Exp Ther; 1996 Jan; 276(1):150-60. PubMed ID: 8558425
[TBL] [Abstract][Full Text] [Related]
22. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
[TBL] [Abstract][Full Text] [Related]
23. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
Perachon S; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
[TBL] [Abstract][Full Text] [Related]
24. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
25. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
[TBL] [Abstract][Full Text] [Related]
26. Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats.
Gleason SD; Yin T; Little SP; Delapp N; Witkin JM
Behav Pharmacol; 2011 Sep; 22(5-6):531-9. PubMed ID: 21836463
[TBL] [Abstract][Full Text] [Related]
27. Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected].
Liu D; Wikström HV; Dijkstra D; de Vries JB; Venhuis BJ
J Med Chem; 2006 Feb; 49(4):1494-8. PubMed ID: 16480286
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of structural requirements for ligands at the dopamine D(2) and D(3) receptor: exploring the thiophene moiety.
Dijkstra D; Rodenhuis N; Vermeulen ES; Pugsley TA; Wise LD; Wikström HV
J Med Chem; 2002 Jul; 45(14):3022-31. PubMed ID: 12086487
[TBL] [Abstract][Full Text] [Related]
29. Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
Luquin MR; Guillén J; Martínez-Vila E; Laguna J; Martínez-Lage JM
Eur J Pharmacol; 1994 Mar; 253(3):215-24. PubMed ID: 7911084
[TBL] [Abstract][Full Text] [Related]
30. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
31. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Smith HP; Nichols DE; Mailman RB; Lawler CP
Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
33. Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype.
Hübner H; Haubmann C; Utz W; Gmeiner P
J Med Chem; 2000 Feb; 43(4):756-62. PubMed ID: 10691700
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
Peng X; Wang Q; Mishra Y; Xu J; Reichert DE; Malik M; Taylor M; Luedtke RR; Mach RH
Bioorg Med Chem Lett; 2015 Feb; 25(3):519-23. PubMed ID: 25556097
[TBL] [Abstract][Full Text] [Related]
35. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Macchia M; Cervetto L; Demontis GC; Longoni B; Minutolo F; Orlandini E; Ortore G; Papi C; Sbrana A; Macchia B
J Med Chem; 2003 Jan; 46(1):161-8. PubMed ID: 12502370
[TBL] [Abstract][Full Text] [Related]
36. 1-substituted apomorphines as potent dopamine agonists.
Reinart-Okugbeni R; Vonk A; Uustare A; Gyulai Z; Sipos A; Rinken A
Bioorg Med Chem; 2013 Jul; 21(14):4143-50. PubMed ID: 23727194
[TBL] [Abstract][Full Text] [Related]
37. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
[TBL] [Abstract][Full Text] [Related]
38. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
Watts VJ; Lawler CP; Knoerzer T; Mayleben MA; Neve KA; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Aug; 239(1-3):271-3. PubMed ID: 8223910
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists.
Matulenko MA; Hakeem AA; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
Bioorg Med Chem; 2004 Jul; 12(13):3471-83. PubMed ID: 15186832
[TBL] [Abstract][Full Text] [Related]
40. CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Wilcox RE; Huang WH; Brusniak MY; Wilcox DM; Pearlman RS; Teeter MM; DuRand CJ; Wiens BL; Neve KA
J Med Chem; 2000 Aug; 43(16):3005-19. PubMed ID: 10956209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
